Racial/ethnic differences in trends of testicular germ cell tumor incidence in the United States, 1992–2021

IF 6.1 2区 医学 Q1 ONCOLOGY
Cancer Pub Date : 2025-01-06 DOI:10.1002/cncr.35706
Andrea A. Almeida MA, MPH, Aika Wojt MS, Catherine Metayer PhD, MD, Peter A. Kanetsky PhD, MPH, Barry I. Graubard PhD, Christian S. Alvarez PhD, MPH, Katherine A. McGlynn PhD, MPH
{"title":"Racial/ethnic differences in trends of testicular germ cell tumor incidence in the United States, 1992–2021","authors":"Andrea A. Almeida MA, MPH,&nbsp;Aika Wojt MS,&nbsp;Catherine Metayer PhD, MD,&nbsp;Peter A. Kanetsky PhD, MPH,&nbsp;Barry I. Graubard PhD,&nbsp;Christian S. Alvarez PhD, MPH,&nbsp;Katherine A. McGlynn PhD, MPH","doi":"10.1002/cncr.35706","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Testicular germ cell tumors (TGCTs) are the most common cancers among young men in the United States. Incidence rates among non-Hispanic White (NHW) men historically have been much higher than the rates among other men. To study whether this pattern had changed, the authors examined trends in TGCT incidence for the years 1992–2021.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>By using the Surveillance, Epidemiology, and End Results 12 registries database, age-standardized incidence rates per 100,000 person-years and 95% confidence intervals (CIs) were calculated overall and by histologic type (seminoma and nonseminoma), age, stage at diagnosis, and race/ethnicity. Trends in 5-year survival also were examined.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The age-standardized incidence rate of TGCT per 100,000 person-years increased from 4.71 (95% CI, 4.39–5.05) in 1992 to 6.22 (95% CI, 5.88–6.58) in 2021. The rates increased for both seminoma (average annual percent change [AAPC], 0.57%; 95% CI, 0.40%–0.75%) and nonseminoma (AAPC, 1.41%; 95% CI, 1.17%–1.64%) and among all race/ethnic groups, although the rates stabilized among NHW men. Increases in incidence were greatest among Hispanic men (AAPC, 3.03%; 95% CI, 2.66%–3.40%), who had one of the youngest median ages at diagnosis and were more likely to be diagnosed at advanced stages compared with NHW men. Seminoma and nonseminoma rates among Hispanic men converged over the study period, whereas seminoma rates remained higher among most other groups.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Hispanic men now have the highest TGCT incidence rates in the United States, although the rates increased among all groups between 1992 and 2021. Racial/ethnic differences in rates require further investigation.</p>\n </section>\n </div>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"131 2","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.35706","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncr.35706","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Testicular germ cell tumors (TGCTs) are the most common cancers among young men in the United States. Incidence rates among non-Hispanic White (NHW) men historically have been much higher than the rates among other men. To study whether this pattern had changed, the authors examined trends in TGCT incidence for the years 1992–2021.

Methods

By using the Surveillance, Epidemiology, and End Results 12 registries database, age-standardized incidence rates per 100,000 person-years and 95% confidence intervals (CIs) were calculated overall and by histologic type (seminoma and nonseminoma), age, stage at diagnosis, and race/ethnicity. Trends in 5-year survival also were examined.

Results

The age-standardized incidence rate of TGCT per 100,000 person-years increased from 4.71 (95% CI, 4.39–5.05) in 1992 to 6.22 (95% CI, 5.88–6.58) in 2021. The rates increased for both seminoma (average annual percent change [AAPC], 0.57%; 95% CI, 0.40%–0.75%) and nonseminoma (AAPC, 1.41%; 95% CI, 1.17%–1.64%) and among all race/ethnic groups, although the rates stabilized among NHW men. Increases in incidence were greatest among Hispanic men (AAPC, 3.03%; 95% CI, 2.66%–3.40%), who had one of the youngest median ages at diagnosis and were more likely to be diagnosed at advanced stages compared with NHW men. Seminoma and nonseminoma rates among Hispanic men converged over the study period, whereas seminoma rates remained higher among most other groups.

Conclusions

Hispanic men now have the highest TGCT incidence rates in the United States, although the rates increased among all groups between 1992 and 2021. Racial/ethnic differences in rates require further investigation.

Abstract Image

1992-2021年美国睾丸生殖细胞肿瘤发病率趋势的种族/民族差异
背景:睾丸生殖细胞肿瘤(tgct)是美国年轻男性中最常见的癌症。历史上,非西班牙裔白人(NHW)男性的发病率远高于其他男性。为了研究这种模式是否发生了变化,作者检查了1992-2021年TGCT发病率的趋势。方法:通过使用监测、流行病学和最终结果12登记处数据库,计算总体和组织学类型(精原细胞瘤和非精原细胞瘤)、年龄、诊断阶段和种族/民族的年龄标准化发病率和95%置信区间(ci)。同时也检查了5年生存率的趋势。结果:TGCT每10万人年的年龄标准化发病率从1992年的4.71 (95% CI, 4.39-5.05)增加到2021年的6.22 (95% CI, 5.88-6.58)。两种精原细胞瘤的发生率均升高(平均年变化率[AAPC], 0.57%;95% CI, 0.40%-0.75%)和非精原细胞瘤(AAPC, 1.41%;95% CI, 1.17%-1.64%),在所有种族/民族群体中,尽管在NHW男性中发病率稳定。西班牙裔男性的发病率增幅最大(AAPC, 3.03%;95% CI, 2.66%-3.40%),他们在诊断时的中位年龄是最年轻的之一,与NHW男性相比,他们更有可能在晚期被诊断出来。在研究期间,西班牙裔男性的精原细胞瘤和非精原细胞瘤发病率趋于一致,而其他大多数群体的精原细胞瘤发病率仍然较高。结论:西班牙裔男性目前在美国的TGCT发病率最高,尽管在1992年至2021年期间,所有组的发病率都有所增加。比率的种族/民族差异需要进一步调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer
Cancer 医学-肿瘤学
CiteScore
13.10
自引率
3.20%
发文量
480
审稿时长
2-3 weeks
期刊介绍: The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信